News

Reports

Notices

News

Number Title Author Date
Notice
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products
alteogen | 2023.01.06 | Votes 0 | Views 1255
alteogen 2023.01.06
Notice
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
alteogen | 2023.01.06 | Votes 0 | Views 728
alteogen 2023.01.06
Notice
Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products
alteogen | 2023.01.06 | Votes 0 | Views 711
alteogen 2023.01.06
Notice
Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology
alteogen | 2023.01.06 | Votes 0 | Views 799
alteogen 2023.01.06
Notice
Alteogen Enters into a Non-exclusive License Agreement with a Global Pharmaceutical Company for Use of Its Hybrozyme™Technology
alteogen | 2023.01.06 | Votes 0 | Views 538
alteogen 2023.01.06
9
24 AUG 2016 Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males
alteogen | 2018.05.28 | Votes 0 | Views 629
alteogen 2018.05.28
8
2 MAR 2016 | Alteogen set to start phase I testing for Herceptin biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 774
alteogen 2018.05.28
7
12 OCT 2015 | Alteogen inks deal with 3Sbio for ADC targeting HER2
alteogen | 2018.05.28 | Votes 0 | Views 703
alteogen 2018.05.28
6
13 JUL 2015 | The patent for long-acting recombinant Alpha-1 Antitrypsin (A1AT)
alteogen | 2018.05.28 | Votes 0 | Views 664
alteogen 2018.05.28
5
30 MAR 2015 | The project with KISSEI has been progressing steadily
alteogen | 2018.05.28 | Votes 0 | Views 620
alteogen 2018.05.28
4
12 DEC 2014 | ALTEOGEN is listed on KOSDAQ
alteogen | 2018.05.28 | Votes 0 | Views 610
alteogen 2018.05.28
3
03 DEC 2014 | NexP™ fusion technology patent registry in EU
alteogen | 2018.05.28 | Votes 0 | Views 603
alteogen 2018.05.28
2
18 AUG 2014 | NexP™ fusion technology patent registry in China
alteogen | 2018.05.28 | Votes 0 | Views 585
alteogen 2018.05.28
1
12 FEB 2014 | ALTEOGEN starts collaboration in mAb biosimilar with KISSEI Pharma.
alteogen | 2018.05.28 | Votes 0 | Views 705
alteogen 2018.05.28